<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Tex Heart Inst J</journal-id><journal-id journal-id-type="iso-abbrev">Tex Heart Inst J</journal-id><journal-id journal-id-type="pmc-domain-id">92</journal-id><journal-id journal-id-type="pmc-domain">thij</journal-id><journal-id journal-id-type="publisher-id">thij</journal-id><journal-title-group><journal-title>The Texas Heart Institute Journal</journal-title></journal-title-group><issn pub-type="ppub">0730-2347</issn><issn pub-type="epub">1526-6702</issn><publisher><publisher-name>Texas Heart Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10658156</article-id><article-id pub-id-type="pmcid-ver">PMC10658156.1</article-id><article-id pub-id-type="pmcaid">10658156</article-id><article-id pub-id-type="pmcaiid">10658156</article-id><article-id pub-id-type="pmid">37853912</article-id><article-id pub-id-type="doi">10.14503/THIJ-22-8055</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Clinical Investigation</subject></subj-group></article-categories><title-group><article-title>Takotsubo Syndrome in Black Americans: Insights From the National Inpatient Sample</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Vriz</surname><given-names initials="O">Olga</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mushtaq</surname><given-names initials="AH">Ali Hassan</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Elshaer</surname><given-names initials="AN">Ahmed Nahid</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shaik</surname><given-names initials="A">Abdullah</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Landi</surname><given-names initials="I">Irene</given-names></name><degrees>MD</degrees><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alzahrani</surname><given-names initials="T">Talal</given-names></name><degrees>MD, MPH</degrees><xref rid="aff5" ref-type="aff">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Heart Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia</aff><aff id="aff2"><label>2</label>Department of Cardiology and Sport Medicine, San Antonio Hospital, San Daniele del Friuli, Udine, Italy</aff><aff id="aff3"><label>3</label>School of Medicine, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia</aff><aff id="aff4"><label>4</label>Department of Translational Medicine, Universit&#224; del Piemonte Orientale, Novara, Italy</aff><aff id="aff5"><label>5</label>Department of Medicine, College of Medicine, Taibah University, Medina, Saudi Arabia</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Olga Vriz, MD, Heart Centre, King Faisal Specialist Hospital and Research Centre, Zahrawi St, Al Maather, Al Maazer, Riyadh 12713, Saudi Arabia (<email>olgavriz@yahoo.com</email>)</corresp><fn><p><bold>Author Contributions:</bold> All authors have read and approved the final version of the manuscript. O.V. contributed to article design, study planning, statistical analysis, and critical article revision. A.H.M, A.N.E., A.S., and T.A. participated in the acquisition of data, data analysis, and manuscript writing. I.L. contributed to the drafting of the article and reviewed the manuscript text.</p></fn></author-notes><pub-date pub-type="collection"><month>9</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-10-19"><day>19</day><month>10</month><year>2023</year></pub-date><volume>50</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">449416</issue-id><elocation-id>e228055</elocation-id><pub-history><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>05</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-21 15:25:36.090"><day>21</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Author(s). Published by The Texas Heart Institute<sup>&#174;</sup></copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use and distribution in any medium, provided the original work is properly cited, and the use is noncommercial.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="i1526-6702-50-5-e228055.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="i1526-6702-50-5-e228055.pdf"/><abstract><title>Abstract</title><sec><title>Background</title><p>Data on race-related differences in the clinical outcomes of Takotsubo syndrome are limited, particularly for Black patients. This study aimed to assess whether race and sex may have an additional impact on the inpatient mortality of patients with Takotsubo syndrome.</p></sec><sec><title>Methods</title><p>A total of 4,628 patients from the United States' National Inpatient Sample from 2012 to 2016 were identified; propensity score analysis revealed a similar propensity score between Black patients (n = 2,314) and White patients (n = 2,314), which was used to balance observed covariates. Sex and age distributions were identical between the 2 groups. The groups were also similar in baseline characteristics, including cardiovascular risk factors. White patients were compared with Black patients on in-hospital outcomes and inpatient mortality. A logistic regression analysis was conducted to measure the difference in mortality based on race and sex.</p></sec><sec><title>Results</title><p>Compared with White patients, Black patients had a higher percentage of in-hospital complications, including cerebrovascular accidents (4.9% vs 2.5%, <italic toggle="yes">P</italic> &#8804; .01), acute kidney injury (25% vs 19%, <italic toggle="yes">P</italic> &#8804; .01); longer lengths of stay (8 vs 7 days, <italic toggle="yes">P</italic> &#8804; .01); and higher inpatient mortality (6.1% vs 4.5%, <italic toggle="yes">P</italic> &lt; .01). When analysis was conducted with race and sex combined, inpatient mortality was higher among Black men than among White women (odds ratio, 2.7 [95% CI, 1.80-3.95]; <italic toggle="yes">P</italic> &#8804; .01).</p></sec><sec><title>Conclusion</title><p>This study showed that Black patients with Takotsubo syndrome have higher in-hospital complications and inpatient mortality rates. When race and sex were combined, inpatient mortality was significantly higher among Black men than among either White men and women or Black women.</p></sec></abstract><kwd-group kwd-group-type="keywords"><kwd>Black people</kwd><kwd>cardiomyopathies</kwd><kwd>mortality</kwd><kwd>postoperative complications</kwd></kwd-group><funding-group><funding-statement><bold>Funding/Support:</bold> None.</funding-statement></funding-group><counts><page-count count="8"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Key Points</title><list list-type="bullet"><list-item><p>Compared with their White counterparts, Black patients with TTS had more CV risk factors and in-hospital adverse outcomes, including longer hospital stays and higher mortality.</p></list-item><list-item><p>Compared with their White counterparts, Black patients with TTS showed a higher rate of inhospital complications, including mortality, even after matching the groups for confounders by propensity score matching.</p></list-item><list-item><p>When race was combined with sex, Black men with TTS showed higher mortality rates, suggesting that sex could unmask the CV predisposition for the worst outcome.</p></list-item></list></sec><sec sec-type="intro"><title>Introduction</title><p>Racial disparities are associated with increased risk of cardiovascular disease (CVD) and poor outcomes, including mortality.<sup><xref rid="i1526-6702-50-5-e228055-b1" ref-type="bibr">1</xref>&#8211;<xref rid="i1526-6702-50-5-e228055-b5" ref-type="bibr">5</xref></sup> In this regard, Black patients appear to have a more substantial burden of CV risk factors (in particular, hypertension and diabetes), lower adherence to therapeutic interventions, and a higher rate of CV complications and mortality than their White counterparts.<sup><xref rid="i1526-6702-50-5-e228055-b6" ref-type="bibr">6</xref>&#8211;<xref rid="i1526-6702-50-5-e228055-b10" ref-type="bibr">10</xref></sup> One CVD with limited race-related data is Takotsubo syndrome (TTS), a disorder characterized by a temporary left ventricle wall motion abnormality and that shares common clinical characteristics with acute coronary syndrome.<sup><xref rid="i1526-6702-50-5-e228055-b11" ref-type="bibr">11</xref>,<xref rid="i1526-6702-50-5-e228055-b12" ref-type="bibr">12</xref></sup> Accumulating data suggest that patients with TTS may have worse short-term<sup><xref rid="i1526-6702-50-5-e228055-b13" ref-type="bibr">13</xref></sup> and long-term<sup><xref rid="i1526-6702-50-5-e228055-b14" ref-type="bibr">14</xref>,<xref rid="i1526-6702-50-5-e228055-b15" ref-type="bibr">15</xref></sup> prognoses than an age- and sex-matched population without TTS.</p><p>This study explored National Inpatient Sample (NIS) data from the Healthcare Cost and Utilization Project to investigate differences in in-hospital outcomes, including mortality, between Black and White patients with TTS.</p></sec><sec sec-type="patients|methods"><title>Patients and Methods</title><sec><title>Study Population</title><p>From the NIS data,<sup><xref rid="i1526-6702-50-5-e228055-b16" ref-type="bibr">16</xref></sup> 27,135 adult patients at least 18 years of age, identified by <italic toggle="yes">International Classification of Diseases, Ninth Revision (ICD-9)</italic> and <italic toggle="yes">International Statistical Classification of Diseases, Tenth Revision (ICD-10)</italic> codes for TTS (<italic toggle="yes">ICD</italic>-9 429.83; <italic toggle="yes">ICD</italic>-10 I51. 81) and admitted to hospital between 2012 and 2016, were included in this study. The final sample consisted of 2,317 Black patients and 24,817 White patients.</p><p>Baseline demographic characteristics&#8212;such as age, sex, body mass index, and year of hospital admission&#8212;and clinical characteristics&#8212;such as smoking status; presence of diabetes, hypertension, or hyperlipidemia; and a history of myocardial infarction (MI), percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG), atrial fibrillation or flutter, peripheral artery disease, and sepsis&#8212;,were identified based on <italic toggle="yes">ICD-9</italic> and <italic toggle="yes">ICD-10</italic> codes. In-hospital outcomes such as length of stay, cardiogenic shock, cardiac arrest, cerebrovascular accidents, invasive mechanical ventilation, mechanical circulation support, acute kidney injury, and mortality were registered using the <italic toggle="yes">ICD-9-Clinical Modification</italic> codes.<sup><xref rid="i1526-6702-50-5-e228055-b17" ref-type="bibr">17</xref></sup></p></sec><sec><title>Statistical Analysis</title><p>Given the observed baseline covariates, a logistic regression model was constructed to calculate the predicted probability and propensity score of being Black for each patient at the time of admission. The propensity score represented the relationship between prespecified baseline characteristics (ie, sex; age; smoking status; presence of diabetes, hypertension, or hyperlipidemia; and history of MI, PCI, CABG, atrial fibrillation or flutter, peripheral artery disease, or sepsis) and being Black as a single characteristic. A matching approach was then used to obtain a matched cohort with a similar propensity score between Black patients and White patients to balance observed covariates.</p><p>The propensity score distribution between the 2 groups in the original sample and the matching sample was compared to assess the balance in the matched cohort that the propensity model produced. The standardized difference was calculated as the mean difference between the 2 groups divided by a measure of the SD of each covariate.</p><p>Baseline demographic and clinical characteristics were reported as a medians for continuous variables and percentages for categorical variables. A Wilcoxon rank sum test and a &#967;<sup>2</sup> test were conducted for continuous and binary variables, respectively, to compare the proposed groups (Black patients and White patients) before and after matching. In-hospital complications and inpatient mortality were compared between the matched groups to determine differences in clinically significant outcomes between Black and White patients.</p><p>The logistic regression model was used to calculate the odds ratio of in-hospital mortality for the combined race-sex effect, using a group of White women as the reference in the matched group after adjusting for baseline characteristics (sex; age; smoking status; presence of diabetes, hypertension, or hyperlipidemia; and history of MI, PCI, CABG, atrial fibrillation or flutter, peripheral artery disease, or sepsis). Statistical analyses were performed using SAS, version 9.4 (SAS Institute Inc) and Stata, version 16 (StataCorp LLC) statistical software. All tests used &#945; = .05 as the probability for a type I error.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Unmatched Population</title><p>The total number of patients admitted with TTS between 2012 and 2016 was 27,135 (median age, 68 years; 86% women). There were 2,317 (8.54%) Black patients and 24,817 (91.46%) White patients. The group of Black patients was younger (63 vs 68 years of age, <italic toggle="yes">P</italic>&lt; .01) and had a lower percentage of women (81% vs 86%, <italic toggle="yes">P</italic> &lt; .01). Black patients were also more likely to have diabetes (31.46% vs 20.81%, <italic toggle="yes">P</italic> &lt; .01) and hypertension (54.9% vs 54.5%, <italic toggle="yes">P</italic> = .01) than their White counterparts. Conversely, hyperlipidemia (39.7% vs 45.4%, <italic toggle="yes">P</italic> = .01) and atrial fibrillation (13.5% vs 21%, <italic toggle="yes">P</italic> &lt; .01) were more frequent in White patients (<xref rid="i1526-6702-50-5-e228055-t01" ref-type="table">Table I</xref>). Black patients had more in-hospital complications; this finding did not change after adjustment for age and sex (<xref rid="THIJ-22-8055.s1" ref-type="supplementary-material">Supplementary Table I</xref>).</p><table-wrap position="float" id="i1526-6702-50-5-e228055-t01" orientation="portrait"><label>TABLE I.</label><caption><p>Differences in Demographic Characteristics Between Black and White Patients With TTS Before Matching</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1">White patients (n = 24,817)</th><th align="left" valign="middle" rowspan="1" colspan="1">Black patients (n = 2,317)</th><th align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<xref rid="nt101" ref-type="table-fn">a</xref></th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="4" rowspan="1">Demographic characteristics</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Female sex, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">21,431 (86.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">1,873 (80.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Age, median, y</td><td align="left" valign="middle" rowspan="1" colspan="1">68</td><td align="left" valign="middle" rowspan="1" colspan="1">63</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" colspan="4" rowspan="1">Clinical characteristics, No. (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Smoker</td><td align="left" valign="middle" rowspan="1" colspan="1">7,146 (28.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">704 (30.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">.11</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Diabetes</td><td align="left" valign="middle" rowspan="1" colspan="1">5165 (20.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">729 (31.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Hypertension</td><td align="left" valign="middle" rowspan="1" colspan="1">13,568 (54.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">1,271 (54.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Hyperlipidemia</td><td align="left" valign="middle" rowspan="1" colspan="1">11,400 (45.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">919 (39.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;History of MI related to coronary artery disease</td><td align="left" valign="middle" rowspan="1" colspan="1">2,896 (11.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">261 (11.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">.56</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;History of PCI</td><td align="left" valign="middle" rowspan="1" colspan="1">1,319 (5.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">96 (4.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">.02</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;History of CABG</td><td align="left" valign="middle" rowspan="1" colspan="1">466 (1.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">33 (1.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">.12</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Atrial fibrillation or flutter</td><td align="left" valign="middle" rowspan="1" colspan="1">5,203 (21.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">313 (13.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Peripheral artery disease</td><td align="left" valign="middle" rowspan="1" colspan="1">1,173 (4.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">109 (4.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">.96</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Sepsis</td><td align="left" valign="middle" rowspan="1" colspan="1">2,546 (10.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">278 (12.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">.01</td></tr></tbody></table><table-wrap-foot><fn><p>CABG, coronary artery bypass graft; MI, myocardial infarction; PCI, percutaneous coronary intervention; TTS, Takotsubo syndrome.</p></fn><fn id="nt101"><p><sup>a</sup><italic toggle="yes">P</italic> &lt; .05 was considered statistically significant.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Matched Population</title><p>Propensity score distribution between the 2 groups in the original sample and the matched sample was used to assess the balance between baseline confounding factors before and after matching. The propensity score distribution differed between the 2 groups in the original sample (<xref rid="i1526-6702-50-5-e228055-f01" ref-type="fig">Fig. 1</xref>) but was similar in the matched sample (<xref rid="i1526-6702-50-5-e228055-f02" ref-type="fig">Fig. 2</xref>). <xref rid="i1526-6702-50-5-e228055-f03" ref-type="fig">Figure 3</xref> shows that the 2 groups' age distribution at admission was similar after matching. <xref rid="i1526-6702-50-5-e228055-f04" ref-type="fig">Figure 4</xref> shows a reduction in the standardized differences in propensity score in the matched sample compared with the original sample. The standardized differences in the matched sample were less than 5%.</p><fig position="float" id="i1526-6702-50-5-e228055-f01" orientation="portrait"><label>Fig. 1</label><caption><p>Propensity score distribution differs between the Black and White patient groups in the original sample</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="i1526-6702-50-5-e228055-f01.jpg"/></fig><fig position="float" id="i1526-6702-50-5-e228055-f02" orientation="portrait"><label>Fig. 2</label><caption><p>Propensity score distribution is similar between the 2 matched groups</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="i1526-6702-50-5-e228055-f02.jpg"/></fig><fig position="float" id="i1526-6702-50-5-e228055-f03" orientation="portrait"><label>Fig. 3</label><caption><p>Age distribution in the 2 matched groups is similar</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="i1526-6702-50-5-e228055-f03.jpg"/></fig><fig position="float" id="i1526-6702-50-5-e228055-f04" orientation="portrait"><label>Fig. 4</label><caption><p>Graph shows a reduction in the standardized differences in propensity score in the matched sample compared with the original sample. The standardized differences in the matched sample were less than 5%.</p><p>CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; MI, myocardial infarction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="i1526-6702-50-5-e228055-f04.jpg"/></fig><p>After matching, 4,628 patients were identified with a similar propensity score between Black patients (n = 2,314) and White patients (n = 2,314). Sex and age distributions were identical between the 2 groups. The 2 groups also had similar baseline characteristics, including CV risk factors (<xref rid="i1526-6702-50-5-e228055-t02" ref-type="table">Table II</xref>). The difference in in-hospital complications between Black patients and White patients is reported in <xref rid="i1526-6702-50-5-e228055-t03" ref-type="table">Table III</xref>. The prevalence rates of cerebrovascular accidents (<italic toggle="yes">P</italic> &lt; .01), length of stay (<italic toggle="yes">P</italic> &lt; .01), and acute kidney injury (<italic toggle="yes">P</italic> &lt; .01) were significantly higher in Black patients. The rate of in-hospital mortality was still significantly higher in Black patients than in White patients (6.1 vs. 4.5, <italic toggle="yes">P</italic> &lt; .01) (<xref rid="i1526-6702-50-5-e228055-t03" ref-type="table">Table III</xref>).</p><table-wrap position="float" id="i1526-6702-50-5-e228055-t02" orientation="portrait"><label>TABLE II.</label><caption><p>Differences in Demographic Characteristics Between Black and White Patients With TTS After Matching</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1">White patients (n = 2,314)</th><th align="left" valign="middle" rowspan="1" colspan="1">Black patients (n = 2,314)</th><th align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<xref rid="nt201" ref-type="table-fn">a</xref></th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="4" rowspan="1">Demographic characteristics</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Female sex, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">1,877 (81.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">1,873 (80.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">.88</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Age, median, y</td><td align="left" valign="middle" rowspan="1" colspan="1">63</td><td align="left" valign="middle" rowspan="1" colspan="1">63</td><td align="left" valign="middle" rowspan="1" colspan="1">.75</td></tr><tr><td align="left" valign="middle" colspan="4" rowspan="1">Clinical characteristics, No. (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Smoker</td><td align="left" valign="middle" rowspan="1" colspan="1">708 (30.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">704 (30.38)</td><td align="left" valign="middle" rowspan="1" colspan="1">.87</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Diabetes</td><td align="left" valign="middle" rowspan="1" colspan="1">734 (31.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">728 (31.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">.85</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Hypertension</td><td align="left" valign="middle" rowspan="1" colspan="1">1,277 (55.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">1,270 (54.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">.84</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Hyperlipidemia</td><td align="left" valign="middle" rowspan="1" colspan="1">909 (39.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">918 (39.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">.79</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;History of MI related to coronary artery disease</td><td align="left" valign="middle" rowspan="1" colspan="1">243 (10.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">261 (11.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">.40</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;History of PCI</td><td align="left" valign="middle" rowspan="1" colspan="1">72 (3.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">95 (4.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">.07</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;History of CABG</td><td align="left" valign="middle" rowspan="1" colspan="1">26 (1.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">33 (1.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">.36</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Atrial fibrillation or flutter</td><td align="left" valign="middle" rowspan="1" colspan="1">292 (12.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">311 (13.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">.41</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Peripheral artery disease</td><td align="left" valign="middle" rowspan="1" colspan="1">84 (3.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">108 (4.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">.08</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;Sepsis</td><td align="left" valign="middle" rowspan="1" colspan="1">262 (11.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">278 (12.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">.46</td></tr></tbody></table><table-wrap-foot><fn><p>CABG, coronary artery bypass graft; MI, myocardial infarction; PCI, percutaneous coronary intervention; TTS, Takotsubo syndrome.</p></fn><fn id="nt201"><p><sup>a</sup>
<italic toggle="yes">P</italic> &lt; .05 was considered statistically significant.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="i1526-6702-50-5-e228055-t03" orientation="portrait"><label>TABLE III.</label><caption><p>Differences Between Black and White Patients With TTS for In-Hospital Complications After Matching</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="middle" rowspan="1" colspan="1">White patients (n = 2,314)</th><th align="left" valign="middle" rowspan="1" colspan="1">Black patients (n = 2,314)</th><th align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<xref rid="nt301" ref-type="table-fn">a</xref></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cardiogenic shock, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">129 (5.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">138 (6.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">.57</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cardiac arrest, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">84 (3.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">103 (4.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">.16</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cerebrovascular accident, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">57 (2.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">113 (4.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mechanical ventilation, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">454 (19.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">496 (21.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">.13</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mechanical support, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">40 (1.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">43 (1.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">.74</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Length of stay, median, d</td><td align="left" valign="middle" rowspan="1" colspan="1">7</td><td align="left" valign="middle" rowspan="1" colspan="1">8</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Acute kidney injury, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">448 (19.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">584 (25.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Inpatient death, No. (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">104 (4.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">142 (6.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr></tbody></table><table-wrap-foot><fn><p>TTS, Takotsubo syndrome.</p></fn><fn id="nt301"><p><sup>a</sup>
<italic toggle="yes">P</italic> &lt; .05 was considered statistically significant.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Logistic Regression Analysis</title><p>A logistic regression analysis in the unmatched groups, adjusted for baseline characteristics, showed a 25% increased mortality rate in Black patients vs White patients (odds ratio, 1.25 [95% CI, 1.03-1.51]; <italic toggle="yes">P</italic> = .02). When sex and race were combined and adjusted for CV risk factors, Black men had the highest mortality rates, followed by White men and Black women (<xref rid="THIJ-22-8055.s1" ref-type="supplementary-material">Supplementary Table II</xref>). The matched groups showed the same results when sex and race were combined: Black men had the highest mortality rates, followed by White men and Black women (<xref rid="i1526-6702-50-5-e228055-t04" ref-type="table">Table IV</xref>).</p><table-wrap position="float" id="i1526-6702-50-5-e228055-t04" orientation="portrait"><label>TABLE IV.</label><caption><p>Risk of Inpatient Mortality Among Matched Groups for Combined Sex and Race<xref rid="nt401" ref-type="table-fn">a</xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="middle" rowspan="1" colspan="1">Odds ratio</th><th align="left" valign="middle" rowspan="1" colspan="1">95% CI</th><th align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<xref rid="nt402" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">White woman</td><td align="left" valign="middle" rowspan="1" colspan="1">[Reference]</td><td align="left" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Black women</td><td align="left" valign="middle" rowspan="1" colspan="1">1.4</td><td align="left" valign="middle" rowspan="1" colspan="1">1.01-1.88</td><td align="left" valign="middle" rowspan="1" colspan="1">.04</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">White men</td><td align="left" valign="middle" rowspan="1" colspan="1">1.9</td><td align="left" valign="middle" rowspan="1" colspan="1">1.22-2.91</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Black men</td><td align="left" valign="middle" rowspan="1" colspan="1">2.7</td><td align="left" valign="middle" rowspan="1" colspan="1">1.80-3.95</td><td align="left" valign="middle" rowspan="1" colspan="1">&lt;.01</td></tr></tbody></table><table-wrap-foot><fn id="nt401"><p><sup>a</sup> A logistic regression model was used to calculate the odds ratio for inpatient death in the matched groups.</p></fn><fn id="nt402"><p><sup>b</sup>
<italic toggle="yes">P</italic> &lt; .05 was considered statistically significant.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Few studies have illustrated the impact of race on patients with TTS, particularly Black patients.<sup><xref rid="i1526-6702-50-5-e228055-b8" ref-type="bibr">8</xref>&#8211;<xref rid="i1526-6702-50-5-e228055-b24" ref-type="bibr">24</xref></sup> Brinjikji et al,<sup><xref rid="i1526-6702-50-5-e228055-b19" ref-type="bibr">19</xref></sup> using data from the 2008-2009 NIS hospital database, reported that race and age were not independently associated with mortality but being male was. Zaghlol et al,<sup><xref rid="i1526-6702-50-5-e228055-b18" ref-type="bibr">18</xref></sup> using data from the 2006-2014 NIS hospital database, compared Black patients (8.2%) and White patients (91.8%) with respect to outcomes and complications. In this case, the authors found that after fully adjusting the data, being Black was not independently associated with worse in-hospital complications and that mortality rates were similar between Black and White patients.</p><sec><title>The Uniqueness of the Present Study</title><p>The present study represents one of the most extensive reports on Black patients admitted to US hospitals with TTS. Key features to be highlighted are (1) Black patients had an overall greater occurrence of CV risk factors and in-hospital outcomes, including length of hospital stay and mortality rates; (2) Black patients had higher in-hospital mortality rates after balancing the study groups by propensity score matching, although CV risk factors were similar between the 2 groups; and (3) when race and sex were combined, sex likely masked the higher susceptibility to mortality in Black men.</p><p>In the unmatched groups, the higher prevalence of CV risk factors in Black patients could be considered the predisposing factor for the worst outcome.<sup><xref rid="i1526-6702-50-5-e228055-b25" ref-type="bibr">25</xref>&#8211;<xref rid="i1526-6702-50-5-e228055-b27" ref-type="bibr">27</xref></sup> In particular, Black men tend to develop hypertension earlier in life than Black women and White individuals, with the onset of related complications starting at a younger age.<sup><xref rid="i1526-6702-50-5-e228055-b6" ref-type="bibr">6</xref>,<xref rid="i1526-6702-50-5-e228055-b26" ref-type="bibr">26</xref></sup> Diabetes is common in patients with TTS, particularly men, and is frequently associated with hypertension.<sup><xref rid="i1526-6702-50-5-e228055-b28" ref-type="bibr">28</xref></sup> Diabetes is also 1 of the main predictors of short-term and long-term mortality in the InterTAK Prognostic Score<sup><xref rid="i1526-6702-50-5-e228055-b15" ref-type="bibr">15</xref></sup> and in other studies<sup><xref rid="i1526-6702-50-5-e228055-b28" ref-type="bibr">28</xref>,<xref rid="i1526-6702-50-5-e228055-b29" ref-type="bibr">29</xref></sup> for patients with TTS. The 2 racial groups were similar, however, in their rates of prior MI and history of PCI and CABG, as reported by others.<sup><xref rid="i1526-6702-50-5-e228055-b13" ref-type="bibr">13</xref>,<xref rid="i1526-6702-50-5-e228055-b30" ref-type="bibr">30</xref></sup> In terms of in-hospital complications, Black patients presented with higher rates of cerebrovascular accident, acute kidney injury, and inpatient mortality and had longer hospital stays than their White counterparts,<sup><xref rid="i1526-6702-50-5-e228055-b18" ref-type="bibr">18</xref>,<xref rid="i1526-6702-50-5-e228055-b21" ref-type="bibr">21</xref></sup> suggesting that race may play a role in the outcomes of Black patients with TTS; this finding is in contrast with those of previous studies.<sup><xref rid="i1526-6702-50-5-e228055-b18" ref-type="bibr">18</xref>,<xref rid="i1526-6702-50-5-e228055-b19" ref-type="bibr">19</xref>,<xref rid="i1526-6702-50-5-e228055-b31" ref-type="bibr">31</xref></sup></p><p>Propensity score matching was used to create 2 balanced groups and overcome the confounding baseline factors between them. The 2 groups were similar in age, sex, CV risk factors, and incidence of CVD, but Black patients still had higher rates of in-hospital complications. When sex and race were combined, mortality rates were significantly higher in Black men, followed by White men and Black women. It is likely that male sex masks a baseline predisposition among Black individuals for the worst outcome. The mechanisms underlying racial differences in TTS outcomes remains to be clarified. Differences in genes that control sympathetic activity, however, and differences in endothelium homeostasis have been identified in Black patients. These distinctive characteristics are associated with increased sympathetic tone, leading to an aggravated CV response to physiologic and psychological stimuli in Black patients compared with White patients.<sup><xref rid="i1526-6702-50-5-e228055-b32" ref-type="bibr">32</xref></sup> Acetylcholine testing could be applied in this setting to highlight the endothelial dysfunction hypothesized to be particularly reactive in Black patients.<sup><xref rid="i1526-6702-50-5-e228055-b33" ref-type="bibr">33</xref></sup> This information, however, is not part of the NIS registry. Male sex characteristics, such as hormone status,<sup><xref rid="i1526-6702-50-5-e228055-b34" ref-type="bibr">34</xref></sup> different gene expressions related to estrogens,<sup><xref rid="i1526-6702-50-5-e228055-b35" ref-type="bibr">35</xref></sup> a higher inflammatory state, whether a physical stressor was involved,<sup><xref rid="i1526-6702-50-5-e228055-b36" ref-type="bibr">36</xref></sup> and higher susceptibility to develop CVD and complications at a younger age<sup><xref rid="i1526-6702-50-5-e228055-b37" ref-type="bibr">37</xref></sup> could explain the poorer outcomes in Black men.</p></sec><sec><title>Limitations</title><p>Study limitations intrinsic to the NIS data set must be addressed. The NIS data set is a retrospective report based on administrative data using <italic toggle="yes">ICD-10</italic> and <italic toggle="yes">ICD-9</italic> coding. Consequently, the accuracy of diagnosis relies entirely on proper coding. The NIS database also captures hospitalizations rather than individual patients. The actual prevalence of TTS in Black patients may therefore need to be considered. Laboratory data (including cardiac biomarkers), electrocardiographic data, and echocardiographic data were also unavailable. Predischarge evaluations for echocardiographic recovery, long-term prognosis information, and prehospital admission events were not provided and could not be considered in the study. Specific diagnostic tests, such as acetylcholine testing for endothelial dysfunction, were not reported and likely not performed in general hospitals. The NIS database registers only in-hospital events, so no prehospital admission data on complications and mortality in general and in events related to TTS in particular were available.</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>The analysis of NIS data highlighted that compared with their White counterparts, Black patients with TTS have distinct clinical characteristics of more frequent, higher CV risk factors. Black patients also showed a higher rate of in-hospital complications, including mortality, even after propensity score matching. When race was combined with sex, Black men showed the highest rate of mortality, suggesting that sex-related factors could unmask the CV predisposition for the worst outcome. There is therefore a rising need to investigate the actual prevalence of TTS among Black patients and develop race-specific prognostic score models and tailored therapeutic interventions.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="THIJ-22-8055.s1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10.14503-THIJ-22-8055.s1.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><fn-group><title>Article Information</title><fn><p><bold>Open Access:</bold> &#169; 2023 The Author(s). Published by The Texas Heart Institute<sup>&#174;</sup>. This is an Open Access article under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/" ext-link-type="uri">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits use and distribution in any medium, provided the original work is properly cited, and the use is noncommercial.</p></fn><fn fn-type="COI-statement"><p><bold>Conflict of Interest/Disclosure:</bold> None.</p></fn></fn-group><glossary><title>Abbreviations and Acronyms</title><def-list><def-item><term>CABG</term><def><p>coronary artery bypass graft</p></def></def-item><def-item><term>CV</term><def><p>cardiovascular</p></def></def-item><def-item><term>CVD</term><def><p>cardiovascular disease</p></def></def-item><def-item><term>ICD-9</term><def><p>International Classification of Diseases, Ninth Revision</p></def></def-item><def-item><term>ICD-10</term><def><p>International Statistical Classification of Diseases, Tenth Revision</p></def></def-item><def-item><term>MI</term><def><p>myocardial infarction</p></def></def-item><def-item><term>NIS</term><def><p>National Inpatient Sample</p></def></def-item><def-item><term>PCI</term><def><p>percutaneous coronary intervention</p></def></def-item><def-item><term>TTS</term><def><p>Takotsubo syndrome</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="i1526-6702-50-5-e228055-b1"><label>1</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Balfour</surname><given-names>PC</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Rodriguez</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ferdinand</surname><given-names>KC</given-names></name></person-group><article-title>The role of hypertension in race-ethnic disparities in cardiovascular disease</article-title><source>Curr Cardiovasc Risk Rep</source><year>2015</year><volume>9</volume><issue>4</issue><fpage>18</fpage><pub-id pub-id-type="doi">10.1007/s12170-015-0446-5</pub-id><pub-id pub-id-type="pmid">26401192</pub-id><pub-id pub-id-type="pmcid">PMC4577235</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b2"><label>2</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Safford</surname><given-names>MM</given-names></name><name name-style="western"><surname>Brown</surname><given-names>TM</given-names></name><name name-style="western"><surname>Muntner</surname><given-names>PM</given-names></name><etal>et al</etal></person-group><article-title>Association of race and sex with risk of incident acute coronary heart disease events</article-title><source>JAMA</source><year>2012</year><volume>308</volume><issue>17</issue><fpage>1768</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.1001/jama.2012.14306</pub-id><pub-id pub-id-type="pmid">23117777</pub-id><pub-id pub-id-type="pmcid">PMC3772637</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b3"><label>3</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Henderson</surname><given-names>SO</given-names></name><name name-style="western"><surname>Haiman</surname><given-names>CA</given-names></name><name name-style="western"><surname>Wilkens</surname><given-names>LR</given-names></name><name name-style="western"><surname>Kolonel</surname><given-names>LN</given-names></name><name name-style="western"><surname>Wan</surname><given-names>P</given-names></name><name name-style="western"><surname>Pike</surname><given-names>MC</given-names></name></person-group><article-title>Established risk factors account for most of the racial differences in cardiovascular disease mortality</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><issue>4</issue><elocation-id>e377</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000377</pub-id><pub-id pub-id-type="pmid">17440613</pub-id><pub-id pub-id-type="pmcid">PMC1847707</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b4"><label>4</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bossone</surname><given-names>E</given-names></name><name name-style="western"><surname>Pyeritz</surname><given-names>RE</given-names></name><name name-style="western"><surname>O'Gara</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Acute aortic dissection in Blacks: insights from the International Registry of Acute Aortic Dissection</article-title><source>Am J Med</source><year>2013</year><volume>126</volume><issue>10</issue><fpage>909</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2013.04.020</pub-id><pub-id pub-id-type="pmid">23953874</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b5"><label>5</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wong</surname><given-names>MD</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>MF</given-names></name><name name-style="western"><surname>Boscardin</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Ettner</surname><given-names>SL</given-names></name></person-group><article-title>Contribution of major diseases to disparities in mortality</article-title><source>N Engl J Med</source><year>2002</year><volume>347</volume><issue>20</issue><fpage>1585</fpage><lpage>1592</lpage><pub-id pub-id-type="doi">10.1056/NEJMsa012979</pub-id><pub-id pub-id-type="pmid">12432046</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b6"><label>6</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Carnethon</surname><given-names>MR</given-names></name><name name-style="western"><surname>Pu</surname><given-names>J</given-names></name><name name-style="western"><surname>Howard</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>Cardiovascular health in African Americans: a scientific statement from the American Heart Association</article-title><source>Circulation</source><year>2017</year><volume>136</volume><issue>21</issue><fpage>e393</fpage><lpage>e423</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000534</pub-id><pub-id pub-id-type="pmid">29061565</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b7"><label>7</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Howard</surname><given-names>G</given-names></name><name name-style="western"><surname>Safford</surname><given-names>MM</given-names></name><name name-style="western"><surname>Moy</surname><given-names>CS</given-names></name><etal>et al</etal></person-group><article-title>Racial differences in the incidence of cardiovascular risk factors in older Black and White adults</article-title><source>J Am Geriatr Soc</source><year>2017</year><volume>65</volume><issue>1</issue><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1111/jgs.14472</pub-id><pub-id pub-id-type="pmid">27666895</pub-id><pub-id pub-id-type="pmcid">PMC5258649</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b8"><label>8</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Howard</surname><given-names>G</given-names></name><name name-style="western"><surname>Prineas</surname><given-names>R</given-names></name><name name-style="western"><surname>Moy</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study</article-title><source>Stroke</source><year>2006</year><volume>37</volume><issue>5</issue><fpage>1171</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000217222.09978.ce</pub-id><pub-id pub-id-type="pmid">16556884</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b9"><label>9</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Taylor</surname><given-names>HA</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Akylbekova</surname><given-names>EL</given-names></name><name name-style="western"><surname>Garrison</surname><given-names>RJ</given-names></name><etal>et al</etal></person-group><article-title>Dyslipidemia and the treatment of lipid disorders in African Americans</article-title><source>Am J Med</source><year>2009</year><volume>122</volume><issue>5</issue><fpage>454</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2008.09.049</pub-id><pub-id pub-id-type="pmid">19375555</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b10"><label>10</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Fiscella</surname><given-names>K</given-names></name><name name-style="western"><surname>Holt</surname><given-names>K</given-names></name></person-group><article-title>Racial disparity in hypertension control: tallying the death toll</article-title><source>Ann Fam Med</source><year>2008</year><volume>6</volume><issue>6</issue><fpage>497</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1370/afm.873</pub-id><pub-id pub-id-type="pmid">19001301</pub-id><pub-id pub-id-type="pmcid">PMC2582461</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b11"><label>11</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ghadri</surname><given-names>J-R</given-names></name><name name-style="western"><surname>Wittstein</surname><given-names>IS</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management</article-title><source>Eur Heart J</source><year>2018</year><volume>39</volume><issue>22</issue><fpage>2047</fpage><lpage>2062</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehy077</pub-id><pub-id pub-id-type="pmid">29850820</pub-id><pub-id pub-id-type="pmcid">PMC5991205</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b12"><label>12</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Murakami</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshikawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Maekawa</surname><given-names>Y</given-names></name><etal>et al</etal></person-group><article-title>Gender differences in patients with Takotsubo cardiomyopathy: multi-center registry from Tokyo CCU Network</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>8</issue><elocation-id>e0136655</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0136655</pub-id><pub-id pub-id-type="pmid">26317750</pub-id><pub-id pub-id-type="pmcid">PMC4552760</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b13"><label>13</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Citro</surname><given-names>R</given-names></name><name name-style="western"><surname>Bossone</surname><given-names>E</given-names></name><name name-style="western"><surname>Parodi</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>Clinical profile and in-hospital outcome of Caucasian patients with Takotsubo syndrome and right ventricular involvement</article-title><source>Int J Cardiol</source><year>2016</year><volume>219</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2016.06.039</pub-id><pub-id pub-id-type="pmid">27387098</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b14"><label>14</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Uribarri</surname><given-names>A</given-names></name><name name-style="western"><surname>N&#250;&#241;ez-Gil</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Conty</surname><given-names>DA</given-names></name><etal>et al</etal></person-group><article-title>Short- and long-term prognosis of patients with Takotsubo syndrome based on different triggers: importance of the physical nature</article-title><source>J Am Heart Assoc</source><year>2019</year><volume>8</volume><issue>24</issue><elocation-id>e013701</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.119.013701</pub-id><pub-id pub-id-type="pmid">31830875</pub-id><pub-id pub-id-type="pmcid">PMC6951081</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b15"><label>15</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wischnewsky</surname><given-names>MB</given-names></name><name name-style="western"><surname>Candreva</surname><given-names>A</given-names></name><name name-style="western"><surname>Bacchi</surname><given-names>B</given-names></name><etal>et al</etal></person-group><article-title>Prediction of short- and long-term mortality in Takotsubo syndrome: the InterTAK Prognostic Score</article-title><source>Eur J Heart Fail</source><year>2019</year><volume>21</volume><issue>11</issue><fpage>1469</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1002/ejhf.1561</pub-id><pub-id pub-id-type="pmid">31452320</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b16"><label>16</label><element-citation publication-type="journal"><person-group><collab>HCUP Methods Series. Healthcare Cost and Utilization Project (HCUP)</collab></person-group><source>Agency for Healthcare Research and Quality</source><month>December</month><year>2022</year><date-in-citation content-type="access-date">Accessed September 5, 2023</date-in-citation><comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.hcup-us.ahrq.gov/reports/methods/methods.jsp" ext-link-type="uri">https://www.hcup-us.ahrq.gov/reports/methods/methods.jsp</ext-link></comment></element-citation></ref><ref id="i1526-6702-50-5-e228055-b17"><label>17</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Quan</surname><given-names>H</given-names></name><name name-style="western"><surname>Sundararajan</surname><given-names>V</given-names></name><name name-style="western"><surname>Halfon</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data</article-title><source>Med Care</source><year>2005</year><volume>43</volume><issue>11</issue><fpage>1130</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1097/01.mlr.0000182534.19832.83</pub-id><pub-id pub-id-type="pmid">16224307</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b18"><label>18</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Zaghlol</surname><given-names>R</given-names></name><name name-style="western"><surname>Dey</surname><given-names>AK</given-names></name><name name-style="western"><surname>Desale</surname><given-names>S</given-names></name><name name-style="western"><surname>Barac</surname><given-names>A</given-names></name></person-group><article-title>Racial differences in Takotsubo cardiomyopathy outcomes in a large nationwide sample</article-title><source>ESC Heart Fail</source><year>2020</year><volume>7</volume><issue>3</issue><fpage>1056</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1002/ehf2.12664</pub-id><pub-id pub-id-type="pmid">32147963</pub-id><pub-id pub-id-type="pmcid">PMC7261569</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b19"><label>19</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Brinjikji</surname><given-names>W</given-names></name><name name-style="western"><surname>El-Sayed</surname><given-names>AM</given-names></name><name name-style="western"><surname>Salka</surname><given-names>S</given-names></name></person-group><article-title>In-hospital mortality among patients with Takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009</article-title><source>Am Heart J</source><year>2012</year><volume>164</volume><issue>2</issue><fpage>215</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2012.04.010</pub-id><pub-id pub-id-type="pmid">22877807</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b20"><label>20</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Qaqa</surname><given-names>A</given-names></name><name name-style="western"><surname>Daoko</surname><given-names>J</given-names></name><name name-style="western"><surname>Jallad</surname><given-names>N</given-names></name><name name-style="western"><surname>Aburomeh</surname><given-names>O</given-names></name><name name-style="western"><surname>Goldfarb</surname><given-names>I</given-names></name><name name-style="western"><surname>Shamoon</surname><given-names>F</given-names></name></person-group><article-title>Takotsubo syndrome in African American vs Non-African American women</article-title><source>West J Emerg Med</source><year>2011</year><volume>12</volume><issue>2</issue><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">21691531</pub-id><pub-id pub-id-type="pmcid">PMC3099612</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b21"><label>21</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Dias</surname><given-names>A</given-names></name><name name-style="western"><surname>Franco</surname><given-names>E</given-names></name><name name-style="western"><surname>Koshkelashvili</surname><given-names>N</given-names></name><name name-style="western"><surname>Pressman</surname><given-names>GS</given-names></name><name name-style="western"><surname>Hebert</surname><given-names>K</given-names></name><name name-style="western"><surname>Figueredo</surname><given-names>VM</given-names></name></person-group><article-title>Racial and ethnic differences in Takotsubo cardiomyopathy presentation and outcomes</article-title><source>Int J Cardiol</source><year>2015</year><volume>194</volume><fpage>100</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2015.04.056</pub-id><pub-id pub-id-type="pmid">26022685</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b22"><label>22</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ravindra</surname><given-names>K</given-names></name><name name-style="western"><surname>Del Buono</surname><given-names>MG</given-names></name><name name-style="western"><surname>Chiabrando</surname><given-names>JG</given-names></name><etal>et al</etal></person-group><article-title>Clinical features and outcomes between African American and Caucasian patients with Takotsubo syndrome</article-title><source>Minerva Cardiol Angiol</source><year>2021</year><volume>69</volume><issue>6</issue><fpage>750</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.23736/S2724-5683.20.05456-0</pub-id><pub-id pub-id-type="pmid">33427424</pub-id><pub-id pub-id-type="pmcid">PMC8422028</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b23"><label>23</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Nascimento</surname><given-names>FO</given-names></name><name name-style="western"><surname>Santana</surname><given-names>O</given-names></name><name name-style="western"><surname>Perez-Caminero</surname><given-names>M</given-names></name><name name-style="western"><surname>Benjo</surname><given-names>AM</given-names></name></person-group><article-title>The characteristics of stress cardiomyopathy in an ethnically heterogeneous population</article-title><source>Clinics (Sao Paulo)</source><year>2011</year><volume>66</volume><issue>11</issue><fpage>1895</fpage><lpage>1899</lpage><pub-id pub-id-type="doi">10.1590/s1807-59322011001100008</pub-id><pub-id pub-id-type="pmid">22086519</pub-id><pub-id pub-id-type="pmcid">PMC3203961</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b24"><label>24</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Patel</surname><given-names>HM</given-names></name><name name-style="western"><surname>Kantharia</surname><given-names>BK</given-names></name><name name-style="western"><surname>Morris</surname><given-names>DL</given-names></name><name name-style="western"><surname>Yazdanfar</surname><given-names>S</given-names></name></person-group><article-title>Takotsubo syndrome in African-American women with atypical presentations: a single-center experience</article-title><source>Clin Cardiol</source><year>2007</year><volume>30</volume><issue>1</issue><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1002/clc.21</pub-id><pub-id pub-id-type="pmid">17262772</pub-id><pub-id pub-id-type="pmcid">PMC6653722</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b25"><label>25</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Nauman</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Race and sex differences in rates of diabetic complications</article-title><source>J Diabetes</source><year>2019</year><volume>11</volume><issue>6</issue><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1111/1753-0407.12869</pub-id><pub-id pub-id-type="pmid">30315628</pub-id><pub-id pub-id-type="pmcid">PMC6462252</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b26"><label>26</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lackland</surname><given-names>DT</given-names></name></person-group><article-title>Racial differences in hypertension: implications for high blood pressure management</article-title><source>Am J Med Sci</source><year>2014</year><volume>348</volume><issue>2</issue><fpage>135</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1097/MAJ.0000000000000308</pub-id><pub-id pub-id-type="pmid">24983758</pub-id><pub-id pub-id-type="pmcid">PMC4108512</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b27"><label>27</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ajuwon</surname><given-names>AM</given-names></name><name name-style="western"><surname>Love</surname><given-names>R</given-names></name></person-group><article-title>Type 2 diabetes and depression in the African American population</article-title><source>J Am Assoc Nurse Pract</source><year>2020</year><volume>32</volume><issue>2</issue><fpage>120</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1097/JXX.0000000000000240</pub-id><pub-id pub-id-type="pmid">31348139</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b28"><label>28</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Stiermaier</surname><given-names>T</given-names></name><name name-style="western"><surname>Eitel</surname><given-names>C</given-names></name><name name-style="western"><surname>Desch</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Incidence, determinants and prognostic relevance of cardiogenic shock in patients with Takotsubo cardiomyopathy</article-title><source>Eur Heart J Acute Cardiovasc Care</source><year>2016</year><volume>5</volume><issue>6</issue><fpage>489</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1177/2048872615612456</pub-id><pub-id pub-id-type="pmid">26474843</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b29"><label>29</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Yerasi</surname><given-names>C</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>B</given-names></name><name name-style="western"><surname>Banga</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Predictors of 90-day readmission and in-hospital mortality in Takotsubo cardiomyopathy: an analysis of 28,079 index admissions</article-title><source>Cardiovasc Revasc Med</source><year>2019</year><volume>20</volume><issue>11</issue><fpage>973</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1016/j.carrev.2019.08.004</pub-id><pub-id pub-id-type="pmid">31488362</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b30"><label>30</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Redfors</surname><given-names>B</given-names></name><name name-style="western"><surname>Jha</surname><given-names>S</given-names></name><name name-style="western"><surname>Thorleifsson</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Short&#8208; and long&#8208;term clinical outcomes for patients with Takotsubo syndrome and patients with myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry</article-title><source>J Am Heart Assoc</source><year>2021</year><volume>10</volume><issue>17</issue><elocation-id>e017290</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.119.017290</pub-id><pub-id pub-id-type="pmid">34465127</pub-id><pub-id pub-id-type="pmcid">PMC8649294</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b31"><label>31</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Imori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kato</surname><given-names>K</given-names></name><name name-style="western"><surname>Cammann</surname><given-names>VL</given-names></name><etal>et al</etal></person-group><article-title>Ethnic comparison in Takotsubo syndrome: novel insights from the International Takotsubo Registry</article-title><source>Clin Res Cardiol</source><year>2022</year><volume>111</volume><issue>2</issue><fpage>186</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1007/s00392-021-01857-4</pub-id><pub-id pub-id-type="pmid">34013386</pub-id><pub-id pub-id-type="pmcid">PMC8816760</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b32"><label>32</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kurnik</surname><given-names>D</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>EA</given-names></name><name name-style="western"><surname>Muszkat</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses</article-title><source>Pharmacogenet Genomics</source><year>2008</year><volume>18</volume><issue>9</issue><fpage>743</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1097/FPC.0b013e3282fee5a1</pub-id><pub-id pub-id-type="pmid">18698227</pub-id><pub-id pub-id-type="pmcid">PMC2689621</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b33"><label>33</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Angelini</surname><given-names>P</given-names></name><name name-style="western"><surname>Uribe</surname><given-names>C</given-names></name><name name-style="western"><surname>Tobis</surname><given-names>JM</given-names></name></person-group><article-title>Pathophysiology of Takotsubo cardiomyopathy: reopened debate</article-title><source>Tex Heart Inst J</source><year>2021</year><volume>48</volume><issue>3</issue><elocation-id>e207490</elocation-id><pub-id pub-id-type="doi">10.14503/THIJ-20-7490</pub-id><pub-id pub-id-type="pmid">34388240</pub-id><pub-id pub-id-type="pmcid">PMC8367283</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b34"><label>34</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Omerovic</surname><given-names>E</given-names></name><name name-style="western"><surname>Citro</surname><given-names>R</given-names></name><name name-style="western"><surname>Bossone</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Pathophysiology of Takotsubo syndrome&#8212;a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology&#8212;part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications</article-title><source>Eur J Heart Fail</source><year>2022</year><volume>24</volume><issue>2</issue><fpage>274</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1002/ejhf.2368</pub-id><pub-id pub-id-type="pmid">34655287</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b35"><label>35</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Pizzino</surname><given-names>G</given-names></name><name name-style="western"><surname>Bitto</surname><given-names>A</given-names></name><name name-style="western"><surname>Crea</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Takotsubo syndrome and estrogen receptor genes: partners in crime?</article-title><source>J Cardiovasc Med (Hagerstown)</source><year>2017</year><volume>18</volume><issue>4</issue><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.2459/JCM.0000000000000500</pub-id><pub-id pub-id-type="pmid">28118181</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b36"><label>36</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Templin</surname><given-names>C</given-names></name><name name-style="western"><surname>Ghadri</surname><given-names>JR</given-names></name><name name-style="western"><surname>Diekmann</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Clinical features and outcomes of Takotsubo (stress) cardiomyopathy</article-title><source>N Engl J Med</source><year>2015</year><volume>373</volume><issue>10</issue><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1406761</pub-id><pub-id pub-id-type="pmid">26332547</pub-id></element-citation></ref><ref id="i1526-6702-50-5-e228055-b37"><label>37</label><element-citation publication-type="journal"><person-group><collab>EUGenMed Cardiovascular Clinical Study Group</collab><name name-style="western"><surname>Regitz-Zagrosek</surname><given-names>V</given-names></name><name name-style="western"><surname>Oertelt-Prigione</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes</article-title><source>Eur Heart J</source><year>2016</year><volume>37</volume><issue>1</issue><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehv598</pub-id><pub-id pub-id-type="pmid">26530104</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>